This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignees: National Institute of Health and Medical Research, Université D'evry-Val-D'essonne, Universite D'evry—val D'essone. Active years: 2020-2022.
Company Filing History:

Years Active: 2020-2022
Title: David Pastre: Innovator in Nucleic Acid Purification and Detection
Introduction
David Pastre is a notable inventor based in Evry, France. He has made significant contributions to the field of molecular biology, particularly in the purification of nucleic acids and the detection of protein interactions in eukaryotic cells. With a total of 2 patents, his work has implications for high-throughput sequencing and diagnostic methods.
Latest Patents
David Pastre's latest patents include innovative methods and tools for purifying nucleic acids. His first patent focuses on techniques that are compatible with high-throughput sequencing and diagnosis. This invention highlights the use of nucleic acid-binding proteins that can be isolated from cell lysates when recruited to polymerized tubulin. The findings indicate that the recovery of nucleic acids is significantly enhanced in the presence of specific trapping proteins.
The second patent involves methods for detecting interactions between proteins in eukaryotic cells using microtubule structures. This method allows for the localization of candidate prey proteins along polymerized tubulin, facilitating the detection of interactions within the cellular environment.
Career Highlights
Throughout his career, David Pastre has worked with esteemed organizations such as the National Institute of Health and Medical Research and the Université d'Évry—Val d'Essonne. His experience in these institutions has contributed to his expertise in molecular biology and biotechnology.
Collaborations
David has collaborated with notable colleagues, including Bénédicte Desforges and Mirela Boca. These partnerships have likely enriched his research and innovation efforts.
Conclusion
David Pastre is a prominent figure in the field of nucleic acid purification and detection. His patents reflect his commitment to advancing scientific knowledge and technology in molecular biology.